admin

Onkogenoks is the brand of Genoks Genetic Diseases Evaluation Center focused on cancer genetics and precision oncology solutions.

The exome refers to all protein-coding regions of the human genome. Although it constitutes only **1–2% of the genome**, more than 85% of known genetic diseases are located within exons. For this reason, exome analysis forms the foundation of modern diagnostic genetic testing.

The exome consists of all protein-coding regions, which make up only 1–2% of the genome. Because the vast majority of genetic diseases originate in these regions, exome analysis has become one of the most critical tools in modern diagnostic genetic testing.

RapidNIPT is a high-accuracy NIPT that screens for 90+ genetic conditions, including Down syndrome, using cfDNA. It is completely risk-free for both the mother and the baby.

Onkogenoks is the brand of Genoks Genetic Diseases Evaluation Center focused on cancer genetics and precision oncology solutions.

The Carrier Screening Test evaluates carrier status for many genetic diseases that are hereditary and mostly autosomal recessive.

RapidNIPT screens for over 90 genetic conditions, including Down syndrome, using cfDNA analysis. It is a non-invasive test that poses no risk to either the mother or the baby and offers a high level of accuracy.

The exome consists of all the protein-coding regions of the genome, even though it makes up only 1–2% of the total genome. Because the great majority of genetic diseases originate in these regions, exome analysis has become one of the most critical tools in today's diagnostic genetic investigations.

G-Health develops personalized solutions in nutrition, skin health, and athletic performance using data derived from each individual's genetic makeup. Every test analyzes DNA-level variations through scientific methods and converts the results into recommendations that can be integrated into daily life.